Indications and uses
temporarily relieves minor aches and pain due to: headache toothache backache menstrual cramps the common cold muscular aches minor pain of arthritis temporarily reduces fever
temporarily relieves minor aches and pain due to: headache toothache backache menstrual cramps the common cold muscular aches minor pain of arthritis temporarily reduces fever
do not take more than directed the smallest effective dose should be used adults and children 12 years and older take 1 tablet every 4 to 6 hours while symptoms persist if pain or fever does not respond to 1 tablet, 2 tablets may be used do not exceed 6 tablets in 24 hours, unless directed by a doctor children under 12 years consult a doctor
Tamper Evident: do not use if safety seal under cap is broken or missing store at room temperature (20 o - 25 o C) avoid excessive heat above 40 o C (104 o F)
Ibuprofen 200 mg (NSAID)*
*nonsteroidal anti- inflammatory drug
Pain Reliever/ Fever Reducer
temporarily relieves minor aches and pain due to:
Ibuprofen may cause a severe allergic reaction, especially in people allergic to Aspirin. Symptoms may include
If an allergic reaction occurs, stop use and seek medical help right away.
This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you
ask a health professional before use. It is especially important not to use ibuprofen during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
| adults and children 12 years and older |
|
| children under 12 years |
|
colloidal silicon dioxide, croscarmellose sodium, FD&C Yellow #6 aluminum lake, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, pregelatinized starch, talc & titanium dioxide
*This product is not manufactured or distributed by McNeil Consumer Healthcare, owner of the registered trademark MOTRIN® IB.
NDC 61715-168-50
*Compare to the active ingredient in MOTRIN® IB.
Preferred plus Pharmacy
IBUPROFEN
Tablets USP 200mg
Pain Reliever / Fever Reducer (NSAID)
50 Tablets
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61715-168-50 | 2025-05-20 | C162847 | 48780-1 | 9d75b9d1-0ec1-f424-e053-dadaa90a57ce | Drug Facts |
| 61715-168-51 | 2025-05-20 | C162847 | 48780-1 | 9d75b9d1-0ec1-f424-e053-dadaa90a57ce | Drug Facts |
| 61715-168-50 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0ec1-f424-e053-dadaa90a57ce | Drug Facts |
| 61715-168-51 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0ec1-f424-e053-dadaa90a57ce | Drug Facts |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 61715-168 | 61715-168-50, 61715-168-51 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| IBUPROFEN | WK2XYI10QM | ACTIB |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| FD&C YELLOW NO. 6 | H77VEI93A8 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| POLYETHYLENE GLYCOL 3350 | G2M7P15E5P | IACT |
| POLYVINYL ALCOHOL | 532B59J990 | IACT |
| STARCH, PREGELATINIZED CORN | O8232NY3SJ | IACT |
| TALC | 7SEV7J4R1U | IACT |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A091237-001 | IBUPROFEN | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A091237-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2011-02-08 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 719d27f5-40e3-4e71-9df6-504324e2e99d | 7cc53a7b-dff7-487a-b0e2-eef7f69b83ef | 2025-05-16 | Warnings | 7cc53a7b-dff7-487a-b0e2-eef7f69b83ef |
Adverse event summaries are temporarily unavailable. Other product information remains available.